205 cs -dengue fever
TRANSCRIPT
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 1/39
Liceo de Cagayan University
R.N. Pelaez Blvd.
Carmen, Cagayan de Oro CityCollege of Nursing
Submitted to:
Mrs. Franelee Zulueta , RN, MN
Submitted by:
GROUP 15
Ortega, Ailyn Joy
Pacapac, Kathleen Love
Padeño, Mercy
Pamabusao, Irish Bette
Pegalan Jenny
Penados, Aiko Louigie
Ramos, Randy
Roque, Mhay Ricamare
Rosales, Kristine Ellen
Sazon, Gian Carlo
Seriña, Roy Jr.
Tan, Jessamine Grace
Tan, Marielle Mae
Villamor, Winberly Fatima
Zornosa, Maria Socorro
December 10, 2009
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 2/39
I. INTRODUCTION
A. OVERVIEW OF THE STUDY
Dengue fever is an infectious disease carried by mosquitoes and caused by any one of
the of four dengue viruses. You can get it if an infected mosquito bites you. This disease used
to be called "break-bone" fever because it sometimes causes severe joint and muscle pain that
feels like bones are breaking, hence the name. Health experts have known about dengue fever
for more than 200 years. It occurs in tropical and sub-tropical areas of the world. Symptoms
appear 3—14 days after the infective bite. Dengue fever is a febrile illness that affects infants,
young children and adults.
Symptoms include a high fever, headaches, joint and muscle pain, vomiting and a rash.
Most people with dengue recover within 2 weeks. Until then, drinking lots of fluids, resting and
taking non-aspirin fever-reducing medicines might help. It is important to maintain hydration.
Sometimes dengue turns into dengue hemorrhagic fever, which causes bleeding from your
nose, gums or under your skin. It can also become dengue shock syndrome, which causes
massive bleeding and shock. These forms of dengue are life-threatening.
Dengue viruses are transmitted to humans through the bites of infective female Aedes
mosquitoes. Mosquitoes generally acquire the virus while feeding on the blood of an infected
person. After virus incubation for eight to 10 days, an infected mosquito is capable, during
probing and blood feeding, of transmitting the virus for the rest of its life. Infected female
mosquitoes may also transmit the virus to their offspring by transovarial (via the eggs)
transmission, but the role of this in sustaining transmission of the virus to humans has not yet
been defined. Infected humans are the main carriers and multipliers of the virus, serving as a
source of the virus for uninfected mosquitoes. The virus circulates in the blood of infected
humans for two to seven days, at approximately the same time that they have a fever; Aedesmosquitoes may acquire the virus when they feed on an individual during this period.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 3/39
The mosquito flourishes during rainy seasons but can breed in water-filled flower pots,
plastic bags, and cans year-round. One mosquito bite can inflict the disease.The virus is not
contagious and cannot be spread directly from person to person. There must be a person-to-
mosquito-to-another-person pathway
Worldwide, 50 to 100 million cases of dengue infection occur each year. This includes
100 to 200 cases in the United States, mostly in people who have recently traveled abroad.
During the last part of the 20th century, many tropical regions of the world saw an increase in
dengue cases. Epidemics also occurred more frequently and with more severity. In addition to
typical dengue, dengue hemorrhagic fever (DHF) and dengue shock syndrome also have
increased in many parts of the world. Globally, there are an estimated several hundred
thousand cases of DHF per year. According to the World Health Organization, there are an
estimated 50 million cases of dengue fever with 500,000 cases of dengue hemorrhagic fever
requiring hospitalization each year. Nearly 40% of the world's population lives in an area
endemic with dengue.
B. OBJECTIVE OF THE STUDY
The study was conducted to determine and identify health problems of the patient to
implement nursing interventions that would alleviate her present condition. And thus, be able to
impart health teachings in promoting health and prevention of illness; be able to relate
applicable recommendations which include referrals and follow-up to intervene on the
problems that are being identified and be able to encourage participation on the promotion of
health and wellness.
C. SCOPE AND LIMITATIONS
This study will act as a baseline data as well as guide for coming up with a good,
reliable, accurate and comprehensive research paper dealing with issues commonly
experienced by patients in the hospital setting. The study focused on one patient admitted at
SABAL HOSPITAL. The time frame of this study begins from the physical assessment last
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 4/39
November 18, 2009 and on the first day of duty last November 19, 2009 up to the 2nd day of
exposure November 20, 2009 11-7 shift at Semi-Private Ward, room 401, Station 2.
Subjective data gathered were taken from the patient alone. The activities include collecting,
organizing, validating and recording any data from the chart, significant others and from our
observation, which will be enough to support our study. We had also identified actual problems
manifested by the patient and implemented nursing intervention. Furthermore, we had also
imparted health teachings that will be beneficial in the promotion of patient’s health. This study
does not involve providing financial assistance or giving false reassurance to the patient as
well as their significant others.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 5/39
II. A. PATIENT’S PROFILE
Name: D.L
Home Address: Kauswagan, CDO
Sex: Female
Age: 15 years old
Religion: Roman Catholic
Civil status: Single
Education level: 4th year high school
Nationality: Filipino
Date admitted: November 18, 2009
Time: 12:21 am
Attending physician: Dr. Sabal
Chief complaint: Fever, Abdominal pain and headache
Admitting diagnosis: Dengue fever
BP: 110/90 mmHg
Pulse rate: 89 bpm
Respiratory rate: 26 cpm
Temperature: 38.7 cHeight: 5’3
Weight: 58.9 kg
B. HISTORY OF PRESENT ILLNESS
Patient D.L 15 years old, a 4th year high school student, who has a history of asthma
and allergic to pollen grains and dust was admitted on Sabal Hospital last November 18, 2009
at 12:21 am with a chief complaint of abdominal and headache.
Prior to admission patient had a fever after being exposed to the rain. She took Biogesic
to relieve her fever but it remained unrelieved so she was brought to the hospital. Upon
admission patient complained of abdominal pain and headache.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 6/39
III. DEVELOPMENTAL DATA
1. ROBERT HAVIGHURST: DEVELOPMENTAL TASK THEORY
In this theory, the patient belongs to the Adolescence. During this age the patient
undergoes the following changes:
A. Achieving new and more mature relations with age- mates of both sexes.
B. Achieving a feminine/ masculine role.
C. Accepting one’s physique and using the body effectively.
D. Achieving emotional independence from parents and other adults.
This explains why the patient seems to give much importance in beautifying self
because this is the time where a person is conscious of the biological changes that take
place in adolescence. We can relate these developmental tasks to patient D. L because
she’s 15 years old and at the time of our care to her, she makes it a point that she’s
neat and clean every time we visit her. She was a bit shy especially when it comes to
performing procedures related to her plan of care.
2. ERIK ERIKSON: EIGHT STAGES OF DEVELOPMENT
In this theory, patient belongs to the Adolescence stage which can be classified
from 12- 20 years old. The Central Task in this stage is Identity versus role confusion.
The indicators of positive resolution are coherent sense of self and plan to actualize
one’s abilities. The indicators of Negative resolution are feelings of confusion,
indecisiveness, and possible antisocial behavior.
To evaluate our patient using this theory, she may fall under the one’s who
manifests positive indicators resolutions. Although our patient may not be that
consistent and active when it comes to conversation, you can very well see that she is
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 7/39
trying to slowly share, that she has plenty of friends in school and that they have similar
likes and dislikes that enabled them to create a bond. Patient D. L was like a typical
teenager that gave importance to her social life and studies. We observed that she
was concerned about her studies because even though she was admitted at the
hospital, she was worried about her absences that could possibly pull down her grades.
Erikson does not believe that the proper solution to a stage crisis is always
completely positive. Some exposure or commitment to the negative end of the person’s
bipolar conflict is sometimes inevitable- you cannot trust all people under all
circumstances and survive, for example. Nonetheless, in the healthy solution to a stage
crisis, the positive resolution dominates
3. SIGMUND FREUD: PSYCHOSEXUAL THEORY OF DEVELOPMENT
Genital stage is the last stage in this theory, this occurs from puberty the after.
Energy is directed towards full sexual maturity and function and development of skills
needed to cope with the environment. This stage implies Encourage separation from
parents, achievement of independence, and decision making.
4. PIAGET’S COGNITIVE DEVELOPMENT
Cognitive Development refers to the manner in which people learn to think,
reason, and use language. It involves a person’s intelligence, perceptual ability, ability
to process information. Cognitive development represents a progression of mental
abilities from illogical to logical thinking, from simple to complex problem solving, and
from understanding concrete ideas to understanding abstract concepts.
According to Piaget (1966), Cognitive development is an orderly. Sequential
process in which a variety of new experiences must exist before intellectual abilities can
develop. Piaget’s phase of cognitive development ends with formal operation phase.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 8/39
In Patient D. L’s age which belongs to the formal operations phase, there is use
of rational thinking and reasoning is deductive and futuristic.
This theory can be used in developing teaching strategies like in the case of
patient D.L, she is 15 years old and can be expected to use rational thinking and to
reason; therefore when explaining the need for a medication, we can outlined the
consequences of taking and not taking the medications that enabled our patient to make
a rational decision.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 9/39
IV. DIAGNOSTIC EXAM
Diagnostic Exam Result Normal Values Significance of the Result
Nov. 17, ‘09
CBCHgb
WBC
Monocytes
Nov. 18, ‘09
CBCHgb
Platelet
Monocytes
Urinalysis
Microscopic
Sp Gravity
Sugar
Pus cell
Epithelial
Albumin
12:05 AM
HematologyPlatelet count
0.36
2.11
0.41
0.36
140
0.14
Yellow
1.015
( - )
3.5
None
( - )
100,000/mm3
0.37- 0.47
3.8- 10.8
00- 0.10
0.37- 0.47
150- 400
00- 0.10
Yellow
1.010-1.025
( - )
0-2
None
( - )
150,000-350,000/mm3
- Anemia, dec. 02capacity of theblood
- Infection- Fever
- Increased withviral infection
- Anemia, dec. 02capacity of theblood
- Dengue fever
- Increased withviral infection
- Normal
- Normal
- Normal
- Presence of bacterial infection
- Normal
- Normal
- Decreasingplatelet countsignifies possible
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 10/39
Platelet count
HematologyPlatelet count
Nov. 19,’0912:05am
HematologyPlatelet count
Nov. 20,’096:11am
HematologyPlatelet count
Platelet count
62,000/mm3
68,000/mm3
100,00/mm3
114,000/mm3
68,0000/mm3
150,000-350,000/mm3
150,000-350,000/mm3
150,000-350,000/mm3
150,000-350,000/mm3
150,000-350,000/mm3
bleeding
- Decreasingplatelet countsignifies possible
bleeding
- Decreasingplatelet countsignifies possiblebleeding
- Decreasingplatelet countsignifies possible
bleeding
- Decreasingplatelet countsignifies possiblebleeding
- Decreasingplatelet count
signifies possiblebleeding
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 11/39
Date Ordered I.V Fluids Clinical significance
Nov. 19, 0912:05 Am
Nov. 19,’09
Nov. 19,’093:00 pm
Nov. 20,’093:30 am
Nov. 20,’0910:45 am
Nov. 20,’095:00 pm
Nov. 20.’09
#5 D5LR 1 L @ 40gtts/min
#6 D5LR 1 L @ 40gtts/min
#7 D5LR 1 L @ 40gtts/min
#8 D5LR 1 L @ 40gtts/min
#9 D5LR 1 L @ 40gtts/min
#10 D5LR 1 L @ 40gtts/min
#11 D5LR 1 L @ 40gtts/min
To replenish fluid andelectrolyte in the bodyand for administration of
IVTT meds
To replenish fluid andelectrolyte in the bodyand for administration of IVTT meds
To replenish fluid andelectrolyte in the bodyand for administration of IVTT meds
To replenish fluid andelectrolyte in the bodyand for administration of IVTT meds
To replenish fluid andelectrolyte in the bodyand for administration of IVTT meds
To replenish fluid andelectrolyte in the bodyand for administration of IVTT meds
To replenish fluid andelectrolyte in the bodyand for administration of IVTT meds
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 12/39
V. A. ANATOMY AND PHYSIOLOGY
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 13/39
B. PATHOPHYSIOLOGY
Dengue Fever Definiton: Is a disease caused by a family of viruses that are transmitted by mosquitoes.
Predisposing factors: Precipitating factors:Gender both SanitationEnvironmental
DENGUE FEVER
↓Causative agent: DENGUE VIRUS TYPES 1,2,3,4
Chikungunya virus↓
INCUBATION PERIOD: 6 days to one week↓SOURCE OF INFECTION :
1. the Aedes Aegypti/ household mosquito2. the infected person.
3 CLASSIFICATIONSMILD MODERATE SEVERE, FRANK
► w/ slight fever w/ high fever w/ flushing
►w/ or without less hemorrhage sudden high fever
► petechial hemorrhage no shock severe hemorrhagesudden drop of temp
shock , death
CLINICAL MANIFESTATIONS:
1st 4 days 4th- 7th days 7th-10th daysFebrile / invasive toxic or hemorrhagic stage Convalescent/ recovery stag
► ↑temp lowering of temp generalized flushing
► Headache severe abdominal pain w/ interventing areas of blanching
► later flushing freq bleeding of GIT appetite regained and BPalready stable
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 14/39
► vomiting hematemesis or melena► epistaxis unstable BP► conjunctival infection narrow pulse pressure► Shock
DIAGNOSTIC TESTTourniquet test (rumple-lead test)
MEDICAL MGT:1. Paracetamol for fever, analgesic for headache, does not give aspirin for shock.2. Fluid replacement3. ORESOL
NURSING MGT:1. Tourniquet test
2. Position patient on dorsal recumbent for shock3. Elevate position for hemorrhage4. DIET: low fat, low fiber, non irritating , non carbonated
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 15/39
VI. DOCTOR’S ORDER
DATE/TIME DOCTOR’S ORDER RATIONALE OF ORDER
11-18-09/12:30 am
11-18-09/6:00 am
11-19-09/12:05 am
Please admit under thecare of Dr. Sabal
Problem: Fever Temperature: every 4 hrs.
No chocolate colored foods
Venoclysis with D5LR @ 40gtts/min
CBC taken @ OPDU/ARepeat CBC @ 6am
Meds: omeprazole 40 mgIVTT now
PCM 500 mg tabevery 4 hrs. >37.8 degreeCelsius
I and O every shift
Monitor V/S every 2 hrs.
Relay labs. To AP
Refer unusualities
IVF TF with D5LR @ SD
For chest xray PA
Isoprinosine 500mg BIDRanitidine 150 mg BID
Fern-C BID
Repeat platelet count exam
For observation andtreatment
To closely monitor temp. for any increase or decrease.
To identify if there is bloodin the stool.
To start administration of IVand meds.
To determine if platelet iswithin normal value.To relieve epigastric pain
To relieve fever
To determine fluid and
electrolytes balance.
To inform AP on lab resultsfor evaluation.To indicate deviation fromnormal and noteimmediately.To follow up electrolytesand avoid imbalances.To determine if lungs arenormal.To treat viral infectionTo neutralize acid in thestomach.To boost immune system.
To monitor platelet count
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 16/39
3:00 pm
11:00 pm
11-20-09/7:00 am
3:00 pm
11:00 pm
TF D5LR 1L @ 40 gtts/min
No new doctors order
No new order’s order
No new order’s order
No new order’s order
No new order’s order
increase or decrease.To maintain fluid andelectrolyte supplementsTo consider continuation of therapy
To consider continuation of therapyTo consider continuation of therapyTo consider continuation of therapyTo consider continuation of therapy
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 17/39
VII. NURSING SYSTEM REVIEW CHARTName: D. L. Date: November 18,2009PR:89 bpm BP: 110/90 mmHg Temp: 38.9 C RR: 26 cpm Weight: 58.9 kg.
EENT:[ ] impaired vision [ ] blind
[ ] pain [ ] reddened [ ] drainage[ ] gums [ ] hard of hearing [ ] deaf Pale conjunctiva[ ] burning [ ] edema [ ] lesion [ ] teeth Pale mucousAssess eyes, ears, nose, membranethroat for abnormality [x ] No problem Productive coughRESP: Dry lips[ ] asymmetric [ ] tachypnea Body Temp: 38.9 C[ ] apnea [ ] rales [ ] cough [ ] barrel chest Poor appetite[ ] bradypnea [ ] shallow [ ] rhonchi Epigastric pain[x] sputum [ ] diminished [ ] dyspnea Dry and pale skin[ ] orthopnea [ ] labored [ ] wheezing Hot skin[ ] pain [ ] cyanotic IVFAssess resp. rate, rhythm, depth, pattern,
breath sounds, comfort [ ] no problemCARDIOVASCULAR:[ ] arrhythmia [ ] tachycardia [ ] numbness[ ] diminished pulses [ ] edema [ ] fatigue[ ] irregular [ ] bradycardia [ ] murmur [ ] tingling [ ] absent pulses [x] painAssess heart sounds, rate rhythm, pulse, bloodPressure, circ., fluid retention, comfort[ ] no problemGASTROINTESTINAL TRACT:[ ] obese [ ] distention [ ] mass[ ] dysphagia [ ] rigidty [x ] painAssess abdomen, bowel habits, swallowing, Body weaknessBowel sounds, comfort [ ] no problemGENITO – URINARY AND GYNE: Limited ROM[ ] pain [ ] urine color [ ] vaginal bleeding[ ] hematuria [ ] discharge [ ] noctoriaAssess urine freq., control, color, odor,Comfort / Gyn-bleeding, discharge[x] No problemNEURO:[ ] paralysis [ ] stuporous [ ] unsteady Infiltrated site[ ] seizure [ ] lethargic [ ] comatose [ ] vertigo[ ] tremors [ ] confused [ ] vision [ ] gripAssess motor function, sensation, LOC, strengthGrip, gait, coordination, orientation, speech[x] no problem
MUSCULOSKELETAL and SKIN:[ ] appliance [ ] stiffness [ ] itching [ ] petechie[x] hot [ ] drainage [ ] prosthesis [ ] swelling[ ] lesion [x ] poor turgor [ ] cool [ ] deformity[ ] wound [ ] rash [ ] skin color [ x] flushed[ ] atrophy [ ] pain [ ] ecchymosis[ ] diaphoretic [ ] MoistAssess mobility, motion gait, alignment, joint function/Skin color, texture, turgor, integrity [ ] no problem
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 18/39
VIII. NURSING ASSESSMENT ll
SUBJECTIVE OBJECTIVECOMMUNICATION[ ]hearing loss Comments[ ]visual changes “wala man koy problema sa
akong pananaw og pandungog”as verbalized by the pt.
[ x ]denied
[ ] Glasses [ ] languages[ ] Contract lens [ ] hearing aide
R LPupil size: 3mm both eyes [ ]speechdifficultiesReaction: (PERRLA) Pupil is Equally Round
Reacted to Light Accommodation
OXYGENATION[ ] Dyspnea Comments[ ] Smoking history “ inig mu-ubo ko kay nay
mugawas na green na plema”as verbalized by the pt.
[x] Cough[x] Sputum[ ] Denied
Resp. [ x ] Regular [ ] Irregular Describe: Pt’s respiratory rate is withinnormal range – 26cpm
R – Right lung is symmetrical to left lung
L – Left lung is symmetrical to right lung
CIRCULATION[ ] Chest pain Comments[ ]Leg pain “okay raman ako pag-ginhawa
Wala man pod ko galisod” asVerbalized by the pt.
[ ]Numbness of Extremities
[x]Denied
Heart Rhythm [ x ] regular [ ] irregular Ankle Edema:
Pulse Car. Rad. AP Fem*R + + +L + + + +Comments: all pulse are palpable*If applicable
NUTRITIONDiet: DAT. No chocolate colored foods[ ]N [ ]V Comments
“gakawalaan ko gana mukaon”As verbalized by the pt.
Character [ x ] Recent change in
Wt., appetite[ ] Swallowing
Difficulty[ ] Denied
[ ] Dentures [ x ] none
Full Partial withpatient
Upper : [ ] [ ] [ ]
Lower: [ ] [ ] [ ]
ELIMINATIONUsual bowel pattern [ ] Urinary Frequency
1 x a day 4 x a day[ ] Constipation [ ] urgency
Remedy [ ] dysuria [ ] Hematuria
CommentsPt. is unable to recall
Bowel sound: Hypoactive sounds 2 mins.
Abdominal Distention
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 19/39
Date of last BM [ ] incontinencenot recalled [ ] Polyuria
[ ] Diarrhea [ ] foly in placeCharacter [ ] Denied
Present [ ] yes [ x ] noUrine* (color,consistency, odor)
yellow colored urine,aromatic odor and moderate amount
MGT. of health & Illness:[ ] Alcohol [ ] Denied(amount, frequency)Pt. has no history of any alcoholic events beingtake place.[ ] SBE last Pap Smear:LMP: not recalled
Not undergone papsmear and SBE
Briefly describe the patient’s ability tofollow treatments ( diet, medication, etc.)from chronic health problems ( if present)
Pt. is cooperative on followingtreatment.
SKIN INTEGRITY
[ x ] Dry Comments[ ] Itching “lain lage ako pamit kau gauga
Og luspad” as verbalized by the pt.[ ]Other [ ]Denied
[ x ] Dry [ ] cold [ ] pale[ ] Flushed [ x ] warm[ ] Moist [ ] cyanotic
*rashes, ulcers, decubitus ( describe size,location, drainage) : Dry skin is beingnoted
ACTIITY/SAFETY[ ] Convulsion Comments[ ] Dizziness “makalakaw man ko pero
Kinahanglan naa koy kauban”As verbalized by the pt.[ x ] Limited motion
of joints
Limitation inAbility to
[ x ] Ambulate[ ] Bathe self [ ] Other [ ] Denied
[ ] LOC and orientation: pt. is oriented todate, time, place, and person.
Gait: [ ] walker [ ] cane [ ] others
[ x ] Steady [ ] Unsteady[ ] Sensory and motor losses in face or extremities : Sensory and Motor losslimited
[ x ] ROM limitations:Pt. is able to walk but with assistance
COMFORT/SLEEP/AWAKE:[ x ] Pain Comments
(location “grabe jud kasakit akong tiyan”As verbalized by the pt.
frequencyremedies)
[ ] nocturia[ x ] sleep difficulties “galisod ko og tulog inig
Gabie kay tugnaw gataki-
[ x ] Facial grimaces[ x ] Guarding[ x ] Other signs of pain: pain scale 10/10
[ ] Siderail release form signed (60 +years)
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 20/39
Gan ko” as verbalized byThe pt.
[ ] denied
COPINGOccupation: noneMembers of household: 4 members of the familyMost supportive person: Mrs. Evelyn (mother)
Observed non-verbal behavior: thesignificant others are supportive andattends the needs of pt.
The person and his phone number thatcan be reached any time: not given
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 21/39
IX. NURSING MANAGEMENT
A. IDEAL NURSING MANAGEMENT
NURSING DIAGNOSIS: Infection, risk for Risk factors may include
Inadequate secondary defenses, e.g., decreased hemoglobin, leukopenia, or decreasedgranulocytes (suppressed inflammatory response) Inadequate primary defenses, e.g., broken
skin, stasis of body fluids; invasive procedures; chronic disease, malnutrition
Possibly evidenced by
[Not applicable; presence of signs and symptoms establishes an actual diagnosis.]
DESIRED OUTCOMES/EVALUATION CRITERIA—PATIENT WILL: Risk Control (NOC)
Identify behaviors to prevent/reduce risk of infection.
Immune Status (NOC)
Be free of signs of infection, achieve timely wound healing (if present).
ACTIONS/INTERVENTIONS
Infection Protection (NIC)
IndependentPerform/promote meticulous handwashing by caregivers and patient.
R: Prevents cross-contamination/bacterial colonization. Note: Patient with severe/aplastic
anemia may be at risk from normal skin flora.
Maintain strict aseptic techniques with procedures/wound care.
R: Reduces risk of bacterial colonization/infection.
Provide meticulous skin, oral, and perianal care.
R: Reduces risk of skin/tissue breakdown and infection.
Encourage frequent position changes/ ambulation, coughing, and deep-breathing exercises.
R: Promotes ventilation of all lung segments and aids in mobilizing secretions to prevent
pneumonia.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 22/39
Promote adequate fluid intake.
R: Assists in liquefying respiratory secretions to facilitate expectoration and prevent stasis of
body fluids (e.g., respiratory and renal).
Stress need to monitor/limit visitors. Provide protective isolation if appropriate. Restrict live
plants/cut flowers.
R: Limits exposure to bacteria/infections. Protective isolation may be required in aplastic
anemia, when immune response is most compromised.
Monitor temperature. Note presence of chills and tachycardia with/without fever.
R: Reflective of inflammatory process/ infection, requiring evaluation and treatment. Note: With
bone marrow suppression, leukocytic failure may lead to fulminating infections.
Observe for wound erythema/drainage
R: Indicators of local infection. Note: Pus formation may be absent if granulocytes are
depressed.
Collaborative
Obtain specimens for culture/sensitivity as indicated.
R: Verifies presence of infection, identifies specific pathogen, and influences choice of
treatment.
Administer topical antiseptics; systemic antibiotics.
R: May be used prophylactically to reduce colonization or used to treat specific infectious
process.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 23/39
IDEAL NURSING CARE PLAN
NURSING DIAGNOSIS: Nutrition: imbalanced, less than body requirements May be
related to
Failure to ingest or inability to digest food/absorb nutrients necessary for formation of normal
RBCs
Possibly evidenced by
Weight loss/weight below normal for age, height, and build Decreased triceps skin-fold
measurement Changes in gums, oral mucous membranes Decreased tolerance for activity,
weakness, and loss of muscle tone
DESIRED OUTCOMES/EVALUATION CRITERIA—PATIENT WILL: Nutritional Status
(NOC)
Demonstrate progressive weight gain or stable weight, with normalization of laboratory values.
Experience no signs of malnutrition. Demonstrate behaviors, lifestyle changes to regain and/or maintain appropriate weight.
ACTIONS/INTERVENTIONS
Nutrition Therapy (NIC)
Independent
Review nutritional history, including food preferences
R: Identifies deficiencies, suggests possible interventions.
Observe and record patient’s food intake.
R: Monitors caloric intake or insufficient quality of food consumption.
Weigh periodically as appropriate (e.g., weekly).
R: Monitors weight loss and effectiveness of nutritional interventions.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 24/39
Recommend small, frequent meals and/or between-meal nourishment.
R: May reduce fatigue and thus enhance intake while preventing gastric distension. Use of
Ensure/Isomil or similar product provides additional protein and calories.
Suggest bland diet, low in roughage, avoiding hot, spicy, or very acidic foods as indicated. R: When oral lesions are present, pain may restrict type of foods patient can tolerate.
Have patient record and report occurrence of nausea/ vomiting, flatus, and other related
symptoms such as irritability or impaired memory.
R: May reflect effects of anemias (hypoxia, vitamin B12 deficiency) on organs.
Collaborative
Consult with dietitian.
R: Aids in establishing dietary plan to meet individual needs.
Monitor laboratory studies, e.g., Hb/Hct, blood urea nitrogen (BUN), prealbumin/albumin,
protein, transferrin, serum iron, vitamin B12, folic acid, TIBC, serum electrolytes.
R: Evaluates effectiveness of treatment regimen, including dietary sources of needed nutrients.
Administer medications as indicated,e.g.:
Vitamin and mineral supplements, e.g., cyanocobalamin (vitamin B12), folic acid
(Folvite), ascorbic acid (vitamin C);
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 25/39
Nursing Diagnosis: risk for imbalanced Fluid volume include risk factors
inadequate fluid intake, bleeding, hyperthermia
Possible evidenced by:
[Not applicable; presence of signs and symptoms establishes an actual diagnosis.]
DESIRED OUTCOMES/EVALUATION CRITERIA—PATIENT WILL: Risk Control
(NOC)
Demonstrate adequate fluid balance as evidenced by stable vital signs, palpable pulses,
normal skin turgor and no edema present.
Actions/Interventions
Independent:note clients age, current level of hydration.
R: this is to provide information regarding ability to tolerate fluid level.
Measure and record I/O.
R:To monitor loss fluid
Note presence of vomiting, liquid stool
R:To include losses in output calculations
Calculate fluid balance(intake>output or output>intake)
R:To prevent fluctuations/imbalances in fluid levels
Auscultate BP, calculate pulse pressure
R:PP widens before systolic BP drops in response to fluid loss.)
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 26/39
Weigh daily or as indicated and evaluate changes
R:Because these may relate to fluid status
COLLABORATIVE:
Administer IV fluids as prescribed
R: to promote fluid management
Assist with rotating tourniquet phlebotomy, dialysis, or ultrafiltration
R: to correct fluid overload situation.
B. ACTUAL NURSING MANAGEMENT (SOAPIE FORM)
S “init lage ako lawas og sakit pud ako ulo” as verbalized by the patient.
O • Increased in body temp. 38c
• Flushed skin, warm to touch
• chills
A Hyperthermia related to illness
P At the end of 30 min. patient’s temp. will be lower down from 38C to 37.5C
I Provided tepid sponge bath May help reduce fever.
Provided adequate fluid intake To prevent dehydration
Reassessed body temperature q 15min.
To determine the effectiveness of theinterventions done.
Monitored client’s temperature,noted shaking chills.
To prevent further complications
Instructed client to have a bed rest. to reduce metabolic demands/oxygenconsumption
Collaborative:Administer antipyretic medication;e.g., paracetamol
To reduce fever and to restore normalbody temperature.
E At the end of the shift, patient’s body temperature was lowered down from 38cto 37.5c
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 27/39
S “Sakit ako tiyan” as verbalized by the patient
O As evidenced by:Facial grimaceGuardingPain scale 7/10
A Acute Pain related to
P At the end of 30 min the patient will be able to verbalize method thatrelief pain
I Independent:-Encouraged use of relation technique such as deep breathing exercise
To minimize pain
-Provided small frequent mealsTo avoid abdominal pain
-Provided position of comfortTo reduce pain and provide comfort
-Encouraged adequate rest periods
To prevent fatigue
Dependent:
- Administer medication as indicated
To reduce pain and muscle spasm
E At the end of 30 minutes the patient was able to verbalized method thatprovide relief.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 28/39
S “Pila nako ka-adlaw na wala na kalibang” as verbalized by the pt.
O As evidenced by:
- Hypo-active bowel sound
A Constipation related to poor eating habit and insufficient fiber intake
P At the end of 30min. pt wil be able to verbalize understanding about
proper life style modification
I Independent:
-Encouraged activity and exercise as toleratedMay reduce potential for constipation by improving stool
consistency and to stimulate contraction of intestine
-Encouraged adequate fluid intake and high fiber ,fruit juicesTo improve consistency of stool, facilitate passage through colon
-Provided information about relationship between diet and exerciseTo provide proper way of elimination
-Encouraged adequate rest periodsTo prevent fatigue
E At the end of 30 min the patient was able to verbalized understandingabout proper life style modification.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 30/39
S “Kapoy kayo ako lawas” as verbalized by the patient
O As evidenced by:
- Generalized body weakness
- Assisted in walking
A Activity Intolerance related to body weakness
P At the end of 30min. pt wil be able to indentify tecniques to enhances
activity toleralnce
I Independent:
-Encourage patient to maintain positives attitude such as relaxationtechnique
To enhance sense of well-being
-Provide positive atmosphereTo minimize fatigue
-Provide patient in planning care between rest period and activityTo reduce weakness
-Plan care with rest periods between activities
To reduce fatigue
-Assist client to learn and demonstrate appropriate safety measureTo prevent injury
E At the end of 30 min the patient was able to indentified techniques toenhance activity tolerance
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 31/39
X. DRUG STUDY
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 32/39
Drug Name: Fern-C
Classification: Vitamin B complex with vita. C
Indication: Prevention and treatment of Vitamin C deficiency enhancesimmune system and resistance to fatigue and muscle weakness.
Dosage/route/frequency: I cap BID P.O
Mechanism of action: Collagen synthesis
Contraindications: Renal impairment due to intake of alcohol
Adverse eactions: Drug toxicity and hypersensitivity
Precautions: Note for any intake of medication to prevent auto-immune reaction of physiologic response
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 33/39
Drug Name: Isoprinosine
Classification: Anti-infectives
Indication: Treatment of various viral infection
Dosage/route/frequency: 500mg BID x7 a day
Mechanism of action: Inhibit growth of bacteria or kill susceptible pathogenic bacteria.
Contraindications: avoid taking without meals
Adverse reactions: transient elevation of urine/serum, uric acid level
skin rashes or itching
gi upset, nausea, fatigue/malaise, constipation, polyuria
Precautions: proper dosage of time, amount of dosage intake assessingfor any drug toxicity. Note for severe psychological drugreactions.
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 34/39
Drug Name: Paracetamol
Classification: Antipyretics
Indication: Mild pain and for fever
Dosage/route/frequency: 500 mg 1 tab q 4 hrs PO
Mechanism of action: Inhibits the synthesis of prostaglandin that may serves asmediators of pain and fever, primarily in the CNS
Contraindications: Contraindicated in previous hypersensitivity.Products containing alcohol. Use cautiously in hepatic disease/renal disease
Adverse eactions: GI hepatic failure, renal failureNeutropenia, leucopeniaRash, urticaria
Precautions: May alter result of blood glucose monitoringAdvise pt to avoid alcohol (3 or more glasses per day to avoid
risk of liver damage
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 35/39
Drug Name: Ranitidine
Classification: Anti-ulcer agents (H2 antagonist)
Indication: Inhibition of gastric acid secretion stress ulcer on upper GI
Dosage/route/frequency: 150 mg BID x 7 days
Mechanism of action: Inhibits the action of histamine at the H2- receptors site locatedprimarily in gastric parietal cells resulting in inhibition of gastric acidsecretion
Contraindications: Contraindicated in hypersensitivity. Use cautiously in in renalimpairement ( more susceptible to CNS reactions)
Adverse reactions: CNS: confusion, dizziness, drowsiness, hallucination, headacheArrythmia
Black tongue, constipation, dark stoolAnemia, neutropenia
Precautions: Assess for epigastric and abdominal pain.Monitor CBC with differentiated periodically during therapy
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 36/39
XI. A. REFERRALS AND FOLLOW-UP
MEDICATION Client is advice to follow strict compliance of home
medications, following strict time and continuous antibiotic
treatment followed meds:
Fern C, Isoprenosole, Ranitidine
RATIONALE:
Home medication should be instructed to ensure that the
essential pharmacologic response is effective by proper
elimination of bacteria and viruses by strict compliance of
medications
EXERCISE Patient is advice to have relaxation techniques such as “Fecal
Imagery” to a non-pharmacological interrelation being made.
Assist client with passive and active range of motion exercise.
RATIONALE:
Fecal Imagery is a higher form of therapeutic response to
ensure a non-dependent response top intervention without the
help of pharmacologic indication
TREATMENT Patient is advice to follow:
Promotion of good rest and avoidance of stressful activities
Compliance to medication
Practice relaxation techniques to provide a therapeutic
response such as medication
RATIONALE:
Non-pharmacologic approach provides a holistic care and
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 37/39
ensures client with treatment compliance to be very effective.
OUT PATIENT Instruct client for a follow up check up by giving a note with a
complete date, specific place and time with reservation of the
attending physician to ensure harmonious check-up.
RATIONALE:
Proper place with the proper time ensures collaborative
measures between the client and the hospital staff to ensure
that the instructions are being given with an accurate
information.
DIET Client is advice to eat nutritious foods with fresh fruits and
vegetables. Increase fluid intake at least 8 glasses per day.
Avoid any alcoholic beverages and soda bottled drink.
RATIONALE:
Optimum quality of vegetables, provide vitamins necessary for
growth of client’s physiologic needs.
Increase fluid intake ensures fluid balance in the body system
and essential nutrients for nutritional balance.
Alcoholic beverages prevents and be avoided to eliminate
waste and junk in the body system.
B. EVALUATION AND IMPLICATIONS
After conducting this care study, We were able to appreciate more the essence of utilizing
the nursing process in the care and management of my patient. It was indeed a tough job on
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 38/39
conducting this study yet, it gave us a big impact regarding how useful it is in our chosen
profession. Nursing really demands a tender loving care attitude. It demands patience and it is
calling that cannot be merely taken for granted.
Moreover, this care study taught us to stand on our own by not depending on others just
to make this. This provides us, the students, a big learning regarding on how well we take care
of or patients in the real clinical setting. Most of all, this study teaches the students to provide
clients care more efficiently and competently to achieve an effective and quality nursing care.
XII. BIBLIOGRAPHY
Medical-Surgical Nursing 11th Edition. Suzanne Smeltzer, Brenda Bare, Janice Hinkle,Kerry Cheever. Volume 1. Pp. 1204 – 1207
8/3/2019 205 CS -Dengue Fever
http://slidepdf.com/reader/full/205-cs-dengue-fever 39/39
Nurse’s Pocket Guide (Diagnoses. Prioritized Interventions, and Rationales) 11th
Edition. Mrilynn E. Doenges, Mary Frances Moorhouse, Alice C. Murr
PPD’s Nursing Drug Guide 2007 Edition
http://www.emedicine.com/MED/topic850.htm